FW:Drug Discovery 2000
rellim at mailhost.tcs.tulane.edu
Thu Apr 27 10:59:41 EST 2000
From: AAAS Member Services <memuser at aaas.org>
Reply-To: AAAS Member Services <memuser at aaas.org>
Date: Wed, 26 Apr 2000 19:03:41 -0500
To: RELLIM at MAILHOST.TCS.TULANE.EDU
Subject: "AAAS Member Discount at DDT 2000"
AAAS would like to invite you to attend IBC's 5th Annual World Congress
Drug Discovery Technology
2000, August 14-17, 2000 in Boston, MA at the World Trade Center and
Seaport Hotel. AAAS members
save 10% on their registration fee - see the end of this email for
This year's event will provide a comprehensive view of the latest drug
discovery technologies and
applications including genomics, target validation, lead generation and
screening, assay development, gene profiling, ADME toxicology,
combinatorial and medicinal chemistry,
miniaturization, chip-based technologies and drug discovery case histories!
Following this year's world
congress is the American Chemical Society Short Courses, August 17-18,
IBC's Drug Discovery Technology 2000 integrates all levels within
pharmaceutical and biotechnology
companies and academic and government drug discovery research groups.
IBC's DDT2000 is THE must
attend event of the year!
Keynote Presentations include:
J Craig Venter, Ph.D., Celera Genomics
Frank Douglas, M.D., Ph.D., Aventis Pharmaceuticals
Steven V. Ley, FRS, University of Cambridge.
With over 2,000 delegates and 225 exhibit booths, IBC's 5th Annual Drug
Discovery Technology 2000 is
the World's Drug Discovery Meeting Place!
Drug Discovery Technology 2000 is supported by Science Magazine and as an
AAAS member, IBC USA
Conferences and AAAS would like to extend to you a 10% discount off the
published registration fee. To
receive this discount, please visit
http://www.drugdisc.com/?source=science1 and enter the Priority Code
'D2473' when prompted on the registration form.
We hope to see you in Boston!
For more information, please contact:
IBC USA Conferences
One Research Drive, Suite 400A
Westborough, MA 01581
Tel: (508) 616-5550
Fax: (508) 616-5553
Email: mailto:klangevin at ibcusa.com
If you do not wish to receive email notifications from AAAS in the future,
or have received this message in error, please reply to this message with
the word UNSUBSCRIBE in the subject and your email address in the body,
and we will remove you from the list promptly.
****DUE TO A SERVER ERROR, YOU MAY HAVE RECEIVED THIS MESSAGE TWICE. IF
YOU'VE ALREADY RECEIVED THIS EMAIL, WE APOLOGIZE FOR THE
More information about the Toxicol